This publication was developed as the outcome of the workshop 'Countermeasure R&D: Global Norms for Financing Risk Reduction, Resilience and Equity' that took place on 18 and 19 January 2022.

Co-convenors of the workshop were the Government of Norway, Government of Mexico, Global Health Centre at the Graduate Institute of Geneva, and the Drugs for Neglected Diseases initiative.